Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
about
Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolitesThe potential use of biomarkers in predicting contrast-induced acute kidney injuryBiomarkers in chronic kidney disease, from kidney function to kidney damageA basic science view of acute kidney injury biomarkers.Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic studyIdentification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxiaChanges in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusionThe primary glomerulonephritides: a systems biology approach.Systems biology of kidney diseases.Early lipid changes in acute kidney injury using SWATH lipidomics coupled with MALDI tissue imaging.Plasma metabolomic profiles in different stages of CKD.Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in RatsPredicting acute kidney injury: current status and future challenges.Comprehensive renal function evaluation in patients treated for synchronous bilateral Wilms tumor.Biomarkers of acute kidney injury.Impact of platinum-based chemotherapy on the progression of atherosclerosis.Metabolic characterization of directly reprogrammed renal tubular epithelial cells (iRECs).
P2860
Q26824720-E83F373C-4B6E-4164-94C3-E60F08D25CB6Q28078393-A9B22297-0F41-4E65-B167-532756CB08D5Q28087304-D37F957D-83AA-4BA4-9F0F-4B18BECD904CQ30384522-E78EF63F-FDD2-4915-9413-0A8D3309E090Q31143152-80FFB18B-F39A-4117-8A9A-41406D861C14Q33810793-EB095E47-8F84-4139-B429-AF621D040ACAQ34078831-EB47FA32-B60F-4496-9938-8AB5F9889504Q34142154-4834309E-CFDB-45C3-B05E-E8E35AABF0CFQ34462626-70E9E62E-4088-48BA-9395-320DC2D6B3D5Q35619034-449FDE4A-99E3-46FC-AF75-C2B4A8B2B626Q35934780-3425170F-9BAF-41FD-9480-553C0424D2D1Q36652795-1F073A57-6DEF-455B-AE18-57454818F2F5Q37704672-CF7BD0FB-BD10-4C4A-BD7B-AD6915D7380BQ38669818-3399A891-FA30-437C-BDB0-3796FA5A1B5FQ40471478-63F51463-3FF4-4D5B-8A9F-0F3592CF8B4FQ41817067-DA3DDF74-184D-4F39-A61F-1E2FD4C84E61Q42822824-6A51EED6-5806-47B5-B0F0-8FE12EA1FD72Q52729435-61D3FCB3-E6B1-4EEA-9E36-A7738DE039DE
P2860
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
@en
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
@nl
type
label
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
@en
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
@nl
prefLabel
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
@en
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
@nl
P2093
P2860
P1476
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
@en
P2093
Didier Portilla
Laura Schnackenberg
Richard D Beger
P2860
P304
P356
10.1016/J.SEMNEPHROL.2007.09.006
P577
2007-11-01T00:00:00Z